AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2023
Feb 14, 2023
30786_dirs_2023-02-14_41d475b9-fd04-40dd-8d07-183e69e27cc1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-02-10
Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | Restricted Stock Units | $0 | A | 644 | Acquired | Bio-Rad A Common Stock (644) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F2: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13